Alvotech

Alvotech is the next name that is listed as one of the largest biotechnology companies in Iceland. It is an institution specializing in biopharmaceuticals, exclusively focused on the development of high-quality biosimilar products. The staff of this company are considered specialists in creating biogeneric products, according to the value chain from cell line development to commercial manufacturing. The organisation's common goals are to be a top business in the biosimilar space and to deliver high-quality cost competitive products to patients over the globe.

With the aim to broaden the abundance of these crucial biologic medicines to patients around the world, Alvotech constantly develops and manufactures high-quality, cost-competitive biosimilars. Moreover, the quality of products is always guaranteed, thus these goods easily get access to the customers. This company also has a deep appreciation for the positive impact that biological medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biological medicines are revolutionizing the way to treat diseases and improve people's health.

In a world where the disease is a leading cause of other serious comorbidities, Alvotech has benefitted countless patients globally. It is managed by a message: If there is a proven biological medicine, it should be accessible to all patients in need.

Founded: 2013

Headquarters: Reykjavík, Iceland

Website: https://www.alvotech.com/